Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;5(Suppl 2):S120-2.
doi: 10.4103/2229-5178.146189.

Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction

Affiliations

Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction

Meet Kumar et al. Indian Dermatol Online J. 2014 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient at presentation
Figure 2
Figure 2
After therapy with oral corticosteroids

References

    1. Nowell PC. Discovery of the Philadelphia chromosome: A personal perspective. J Clin Invest. 2007;117:2033–5. - PMC - PubMed
    1. Guilhot F. Indications for imatinib mesylate therapy and clinical management. Oncologist. 2004;9:271–81. - PubMed
    1. Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol. 2005;6:491–500. - PubMed
    1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) Semin Cutan Med Surg. 1996;15:250–7. - PubMed
    1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–11. - PubMed